Autopsy report · NCT02431104

Clinical Evaluation of Tattoo Removal Using a Novel Dual-Wavelength, Dual-Pulse Duration Laser

“Sponsor terminated study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Cutera Inc.

Sponsor type

Industry

Conditions

Laser Tattoo Removal

Interventions

532-nm KTP/1064-nm Nd:YAG Dual-Pulse Duration Laser

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
  “Study terminated at Sponsor's request.” (96% match in meaning)
• Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
  “Study terminated by the Sponsor” (95% match in meaning)
• Visual Function Tests in Age-related Macular Degeneration
  “Study terminated by Sponsor” (94% match in meaning)
• Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
  “The Sponsor terminated the study.” (94% match in meaning)
• Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs
  “Study terminated based on decision of Sponsor.” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.